Posted on March 21, 20253/21/25
Capital Efficient Commercialization: A New Model for Success
Posted on March 21, 20253/21/25
Boosting Pharma Efficiency: A New Model for Asset Value Retention
Posted on March 2, 20253/2/25
The Path to Maximizing Revenue: How to Simplify Pharmaceutical Commercialization and Find Optimum Success
Posted on February 21, 20252/21/25
Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficiency
Posted on January 6, 20251/6/25
Beyond Theory: Integrated Commercialization Model Proves Valuable in Launch Success
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on September 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on August 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on July 17, 20247/17/24
In-Depth with an Industry Leader: Global Launch Ambitions and Paradigm Shifts
Posted on April 16, 20244/16/24